Your browser doesn't support javascript.
Late and booster anti-SARS-CoV-2 humoral responses in nonresponder vaccinated patients with rheumatic diseases receiving mycophenolate or rituximab: comment on the article by XXX et al.
Bakasis, Athanasios-Dimitrios; Goules, Andreas V; Vlachoyiannopoulos, Panayiotis G; Bitzogli, Kleopatra; Tzioufas, Athanasios G.
  • Bakasis AD; Department of Pathophysiology and School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Goules AV; Institute for Autoimmune Systemic and Neurologic Diseases, Athens, Greece.
  • Vlachoyiannopoulos PG; Department of Pathophysiology and School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Bitzogli K; Institute for Autoimmune Systemic and Neurologic Diseases, Athens, Greece.
  • Tzioufas AG; Department of Pathophysiology and School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
ACR Open Rheumatol ; 4(8): 645-646, 2022 Aug.
Article in English | MEDLINE | ID: covidwho-1849974
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines Language: English Journal: ACR Open Rheumatol Year: 2022 Document Type: Article Affiliation country: Acr2.11446

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines Language: English Journal: ACR Open Rheumatol Year: 2022 Document Type: Article Affiliation country: Acr2.11446